FOXP3 and obesity disorder: The anti-inflammatory action of Foxp3+ T cells (Tregs) has been proposed to alter insulin sensitivity, as obesity is accompanied by both a reduction in the proportion of this T cell population and the development of insulin resistance (Feuerer et al., 2009).